Zharp2-1

Customer Review

Based on 1 Customer Validation

Zharp2-1 is an oral effective RIPK2 inhibitor, highly associated with inflammatory bowel disease (IBD). Zharp2-1 blocker muramyl dipeptide (MDP) induces growth of mononuclear cells and induces inflammatory cell factor infection. Zharp2-1 attenuates MDP-induced small inguinal peritonitis, or ameliorates by DNBS-induced large inguinal conjunctivitis.

For research use only. We do not sell to patients.

  • Purity: 99.10%
  • CAS No.: 2772600-18-5
  • Formula: C19H18N3O2PS
  • Molecular Weight:383.40
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All RIP kinase Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00